After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Yahoo Finance discussed the stock recently as it posted Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Alkermes plc is listed on the NASDAQ in the Healthcare sector while operating in the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of Alkermes plc is $4.83B. A total of 1.55 million shares were traded on the day, compared to an average of 2.29M shares.
In the most recent transaction, Parisi Samuel Joseph sold 2,559 shares of ALKS for 29.65 per share on Feb 27 ’24. After the transaction, the VP, Finance (Interim PAO) now owns 7,717 company shares. In a previous transaction on Feb 15 ’24, LAURENCIN CATO T sold 2,690 shares at 31.85 per share. ALKS shares that Director owns now total 15,169.
Among the insiders who sold shares, LAURENCIN CATO T disposed of 2,638 shares on Jun 08 ’23 at a per-share price of $31.85. This resulted in the Director holding 7,479 shares of ALKS after the transaction. In another insider transaction, LAURENCIN CATO T sold 2,800 shares at $31.50 per share on Jun 07 ’23. Company shares held by the Director now total 7,479.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, ALKS has a high of $32.88 and a low of $20.46.
As of this writing, ALKS has an earnings estimate of $0.69 per share for the current quarter. EPS was calculated based on a consensus of 6 estimates, with a high estimate of $0.92 per share and a lower estimate of $0.58. The company reported an EPS of $0.64 in the last quarter, which was 45.50% higher than expectations of $0.44.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. ALKS’s latest balance sheet shows that the firm has $536.31M in Cash & Short Term Investments as of fiscal 2021. There were $416.21M in debt and $471.29M in liabilities at the time. Its Book Value Per Share was $7.20, while its Total Shareholder’s Equity was $1.11B.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ALKS is Buy with a score of 3.83.
